Sacubitril valsartan in real life: tolerance, clinical evolution and remodeled long term

25 May 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Rafael Bravo-Marques

University Hospital Costa del Sol, Marbella (Spain)

10 More presentations in this session

Presentation thumbnail

Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus

Doctor R. Bravo-Marques (Marbella, ES)

Presentation thumbnail

Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment

Doctor C. Goena Vives (Donostia, ES)

Abstract Slides

Presentation thumbnail

Long-term prognostic impact of beta-blocker prescription during hospitalization for acute myocardial infarction

Doctor F. Fonseca Goncalves (Vila Real, PT)

Abstract Slides

Presentation thumbnail

Diabetic patients need higher loop diuretic doses: a report on acute and chronic heart failure patients

Associate Professor P. Bettencourt (Porto, PT)

Presentation thumbnail

Progression of markers of cardiac structure and function in the Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) clinical trial

Professor M. Ledwidge (Dublin, IE)

Access the full session

Session thumbnail

Poster Session 1 - Pharmacology and Pharmacotherapy

The Event

Heart Failure 2019

25 May - 28 May 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources